|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.440 USD | -1.37% |
|
-7.69% | -82.07% |
| 10-07 | Top Midday Gainers | MT |
| 10-07 | Lipocine Inc. Through Verity Pharmaceuticals Inc Announces Health Canada Approval of Tlando for Testosterone Replacement Therapy in Adult Males | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LPCN | Delayed | |
CBOE
| LPCN | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.796 | 1.94 | 3.99 |
| Spread/Res. | -19.82% | -25.77% | -63.91% |
| Spread/Supp. | +15.63% | +15.63% | +38.20% |
| Support | 1.245 | 1.245 | 1.042 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LPCN Stock
- Charts Lipocine Inc.
Select your edition
All financial news and data tailored to specific country editions
